 VI. To examine, when available, post treatment tumor biopsies for vascular markers to detect decreased vascular proliferation by staining cluster of differentiation 31 CD31, vascular endothelial growth factor VEGF, thrombospondin-1, and cluster of differentiation 105 CD105 staining to monitor micro vessel density. 